Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Ipilimumab × Clear all

Phase

Status

Completed 6 Active not recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 13 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 4 Uveal Melanoma 3 Prostatic Neoplasms 3 Sarcoma 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Brain Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous-Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Diseases 1 Osteosarcoma 1 Neoplastic Cells, Circulating 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 Metastatic Microsatellite Stable Colorectal Cancer 1 Kidney Neoplasms 1 Hypoxia 1 Head and Neck Neoplasms 1 Genital Neoplasms, Male 1

Interventions

Cisplatin 28 Radiotherapy 16 Paclitaxel 9 Surveys and Questionnaires 8 Fluorouracil 8 Cetuximab 8 pembrolizumab 7 durvalumab 6 Docetaxel 6 apatinib 5 Radiotherapy, Intensity-Modulated 5 Low-Level Light Therapy 5 Carboplatin 5 Standard of Care 4 Gemcitabine 4 Celecoxib 4 atezolizumab 3 Radiation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Cyclophosphamide 3 Blood Specimen Collection 3 Biopsy 3 toripalimab 2 fludarabine 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03700905 2023-05-23

IMSTAR-HN

Universitätsklinikum Hamburg-Eppendorf

Phase 3 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡